Last Price
1.42
Today's Change
+0.486 (52.03%)
Day's Change
0.795 - 2.21
Trading Volume
125,351,347
Market Cap
7 Million
Shares Outstanding
5 Million
Avg Volume
410,387
Avg Price (50 Days)
1.07
Avg Price (200 Days)
1.20
PE Ratio
-0.53
EPS
-2.74
Earnings Announcement
09-Nov-2024
Previous Close
0.93
Open
0.84
Day's Range
0.7946 - 2.2101
Year Range
0.61 - 5.225
Trading Volume
125,536,240
1 Day Change
54.44%
5 Day Change
53.58%
1 Month Change
8.65%
3 Month Change
20.42%
6 Month Change
-21.47%
Ytd Change
-48.39%
1 Year Change
-69.26%
3 Year Change
-98.25%
5 Year Change
-98.36%
10 Year Change
-98.36%
Max Change
-98.36%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.